Form 4: Trulieve Cannabis Corp. Executive Kyle Landrum Receives Stock Options and Restricted Stock Units

Kyle Landrum, Chief Production Officer of Trulieve Cannabis Corp., reports the acquisition of stock options and restricted stock units.

Summary

• On March 8, 2024, Kyle Landrum, Chief Production Officer of Trulieve Cannabis Corp., was granted 37,500 restricted stock units (RSUs) and options to purchase 67,902 subordinate voting shares.
• The RSUs vest in two installments: 50% on December 1, 2025, and the remaining 50% on December 1, 2026.
• The stock options, with an exercise price of $10, vest in three annual installments starting December 1, 2024, and expire on March 8, 2031.
• Following these transactions, Landrum directly owns 122,150 subordinate voting shares and options to purchase 67,902 subordinate voting shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of equity suggests confidence in the company's future, but it's a routine transaction.

Positives

• The grant of RSUs and stock options to a key executive like the Chief Production Officer suggests an incentive alignment with the company's long-term performance.
• The vesting schedules for both RSUs and stock options encourage continued service and commitment from the executive.

Future Outlook

The document does not contain specific forward-looking statements about the company's future performance, but the equity grants suggest an expectation of future growth and value creation.

Industry Context

Equity compensation is a common practice in the cannabis industry to attract and retain talent, aligning executive incentives with shareholder value creation in a high-growth sector.

Comparison to Industry Standards

• Comparing Trulieve's executive compensation structure to peers like Curaleaf, Green Thumb Industries, and Canopy Growth would provide a benchmark for assessing the competitiveness and appropriateness of the grants.
• Industry standards for vesting schedules typically range from 3 to 5 years, with annual or quarterly vesting tranches, similar to Trulieve's three-year vesting for options and two-year vesting for RSUs.
• The exercise price of $10 for the stock options should be compared to the current market price of Trulieve's shares to determine the 'in-the-money' or 'out-of-the-money' status of the options.

Stakeholder Impact

• Shareholders may view the equity grants positively as aligning management's interests with long-term value creation.
• Employees may see the grants as a sign of the company's commitment to its leadership team.

Key Dates